Clinical trials: Prognostic Factors
Opioid-use Disorder
Treatment for Opiate Addiction: Prognostic fActors of Responsiveness to Maintenance Treatment
A global and integrative treatment of opioid-use disorders (OUD) with opiate maintenance therapy (OMT) and psychosocial interventions is recommended by all current guidelines.
- Trial name
- TOPAZE (NCT03729388)
- Testing
- Prognosis factor associated with good outcome.
- Where
- 2 sites in France
- Volunteers
- 29 people
- Sponsor
- Nantes University Hospital
Salivary Gland Cancer, Salivary Gland Neoplasms
Survival With Patients Treated With Salivary Gland Cancer
Salivary gland malignancies is very heterogenous group of tumors regarding tumor histology and localization. The aim of this study is to assess main clinical and pathological parameters related to patients survival
- Trial name
- NCT05390294
- Testing
- Surgical intervention with or without postoperative adjuvant therapy
- Where
- Serbia
- Volunteers
- 250 people
- Sponsor
- Clinical Center of Vojvodina
Pancreatic Adenocarcinoma, Colorectal Cancer
Micrometastasis in Gastrointestinal Cancer
Prognostic and predictive value of assessing the patients micrometastasis status in blood and bone marrow when diagnosed GI cancer.
- Trial name
- NCT01919151
- Where
- Norway
- Volunteers
- 500 people
- Sponsor
- Oslo University Hospital
Mortality, Shock
Hydrogen Sulfide as Prognostic Factor
Hydrogen sulfide (H2S), better known as a poisonous gas, has emerged as the third gaseous transmitter in mammals, next to nitric oxide (NO) and carbon monoxide (CO).
- Trial name
- H2S-1 (NCT01088490)
- Where
- Slovenia
- Volunteers
- 50 people
- Sponsor
- University Medical Centre Ljubljana
Metastatic Colorectal Cancer (CRC), Antineoplastic Agents, Immunological
Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metastatic Colorectal Cancer
The main objective of this study is to identify the prognostic factors (clinico-biological) for the efficacy (overall survival) of fruquintinib in patients with metastatic colorectal cancer.
- Conditions
- Metastatic Colorectal Cancer (CRC), Antineoplastic Agents, Immunological, VEGFR-TKI
- Trial name
- COFRUQ (NCT07124858)
- Testing
- Fruquintinib
- Where
- 83 sites in France
- Volunteers
- 300 people
- Sponsor
- Federation Francophone de Cancerologie Digestive
Rectal Cancer, Lymph Node Metastases
FDG - PET / MRI in Patients With Rectal Cancer
The combination of FDG-PET/CT and MRI at staging of rectal cancer in diagnosis is currently very little studied. The investigator have a unique opportunity to study this.
- Trial name
- RECTOPET (NCT03846882)
- Where
- Sweden
- Volunteers
- 100 people
- Sponsor
- Region Västerbotten
Carcinoma, Renal Cell, Clear Cell Renal Cell Carcinoma
Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors
Aim of the FavorAx study is to evaluate preliminary efficacy and safety of Axitinib in metastatic renal cell carcinoma patients with favorable IMDC prognostic factors who had progressed on sunitinib or pazopanib in the first-line…
- Trial name
- FavorAx (NCT02700568)
- Testing
- axitinib
- Where
- 15 sites in Russia
- Volunteers
- 21 people
- Sponsor
- Kidney Cancer Research Bureau
Neoplasms Pancreatic
A New Prognostic Score Model for Pancreatic Ductal Adenocarcinoma
The AJCC TNM staging system is the prevailing method in prognostic evaluation of pancreatic ductal adenocarcinoma (PDAC) at present , but it did not include factors such as the tumor immune microenvironment that are known to…
- Trial name
- NCT05547074
- Testing
- pancreatic cancer surgery
- Where
- China
- Volunteers
- 302 people
- Sponsor
- Zhejiang University
Pneumonia
Procalcitonin at Zero and 24 Hours as a Prognostic Factor in Patients With Pneumonia
Procalcitonin levels checked initially and at 24 hours will correlate with disease severity, morbidity, and mortality. Patients who have a higher procalcitonin level initially and at 24 hours will likely have higher qSOFA scores…
- Trial name
- NCT03711227
- Testing
- Procalcitonin lab test
- Where
- United States
- Volunteers
- 185 people
- Sponsor
- Corewell Health South
Systolic Heart Failure, Diastolic Heart Failure
Psychosocial Patterns and Prognosis in Patients With Heart Failure
This prospective observational study is designed to confirm the prognostic and economic impact of depression in ambulatory patients with systolic or diastolic heart failure, to explore the impact of other psychosocial patterns…
- Trial name
- PANIC (NCT00709241)
- Where
- France
- Volunteers
- 325 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Cervical Cancer
Clinical and Pathological Characteristics as Prognostic Factors in Locally Advanced Cervical Cancer
Locally advanced cervical cáncer continues to be a public health problem in emergent economies, even though treatment is very well standardized, recurrence rate is still high, making necessary to evaluate prognostic clinical and…
- Trial name
- NCT04537273
- Testing
- Descriptive and analytical
- Volunteers
- 1,954 people
- Sponsor
- National Institute of Cancerología
Neuroendocrine Carcinoma
PrognostIc and Predictive Factors in Unresectable Locally Advanced NEC and MANEC
Extra-pulmonary (EP) poorly differentiated neuroendocrine carcinomas (NECs) represent a rare and aggressive category of neoplasms.
- Trial name
- NIRVANA (NCT06400654)
- Where
- Italy
- Volunteers
- 100 people
- Sponsor
- European Institute of Oncology
Low Back Pain, Life Style
Prognostic Factors of Importance on Who Develops Chronic Low Back Pain
The incidence of low back pain (LBP) is increasing and prognostic factors for developing LBP are unclear. Based on questionnaires, different prognostic factors are being explored over time.
- Conditions
- Low Back Pain, Life Style, Illness Perception
- Trial name
- NCT03940456
- Testing
- Questionnaire
- Where
- Denmark
- Volunteers
- 607 people, healthy volunteers welcome
- Sponsor
- Frederiksberg University Hospital
Myotonic Dystrophy
DM1 Heart Registry - DM1 Respiratory Registry
Myotonic dystrophy type 1 (DM1) is the most frequent neuromuscular disease in adults. DM1 patients have an impaired prognosis (mean age of death <60 years) due to cardiac and respiratory complications.
- Trial name
- DM1-Heart-R (NCT01136330)
- Where
- France
- Volunteers
- 914 people
- Sponsor
- Institut de Myologie, France
Early-stage Invasive Lobular Breast Carcinoma
AI-based Prognostic Factors Identification in Early-stage Invasive Lobular Breast Carcinoma
Invasive lobular breast carcinoma (ILC), the second most common breast cancer type, represents approximately 15% of all breast cancer cases.
- Trial name
- NCT07842055
- Where
- Greece
- Volunteers
- 3,648 people
- Sponsor
- Hellenic Cooperative Oncology Group
Myelodysplastic Syndrome
Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and Relapse in Myelodysplastic Syndrome
Developing a molecular genetic test that can identify prognostic factors which can predict response to treatment, and to contribute to the establishment of future therapeutic strategies base on prognostic factors by undergoing…
- Trial name
- NCT02330692
- Testing
- No intervention
- Where
- South Korea
- Volunteers
- 1,000 people
- Sponsor
- Yonsei University
Rotator Cuff Related Shoulder Pain, RCRSP
Profiling Patients With Rotator Cuff Related Shoulder Pain: What Factors Influence Outcomes With Non-operative Care in a Secondary Care Specialist Shoulder Clinic?
Shoulder pain from rotator cuff disorders is common, affecting function and quality of life. Many patients in orthopaedic clinics are diagnosed with these conditions.
- Trial name
- NCT07360847
- Where
- Ireland
- Volunteers
- 150 people
- Sponsor
- University of Limerick
Liver Injury
Liver Injury in Patients With COVID-19
Coronavirus disease was first diagnosed in December 2019, in the city of Wuhan, China. The World Health Organization recently declared coronavirus disease 2019 (COVID-19) as a pandemic.
- Trial name
- NCT04358380
- Testing
- Liver injury
- Where
- Argentina
- Volunteers
- 320 people
- Sponsor
- Austral University, Argentina
Sacrococcygeal Teratoma
Improving Prenatal Parental Counseling in Cases of Sacrococcygeal Teratoma
Sacrococcygeal teratoma (SCT) is the most common fetal and neonatal tumor. However, predicting factors of evolution, sequelae and relapse are still unreliable because of small-cohort studies.
- Trial name
- PROSTEO (NCT04623658)
- Where
- France
- Volunteers
- 84 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Diffuse Large B Cell Lymphoma
Real-Time Monitoring of Circulating Tumor DNA and Study of Prognostic Factors in Patients Treated With CAR-T Cells
The purpose of this study is to demonstrate that it is possible to report in real time (less than 3 weeks) to the hematologist the results of the molecular minimal residual disease (MRD) based on blood circulating tumor DNA…
- Trial name
- RT-CAR (NCT05675982)
- Testing
- CAR-T cells monitoring
- Where
- France
- Volunteers
- 40 people
- Sponsor
- Centre Henri Becquerel